<p>华尔街 Zen 的分析师将 Stryker (NYSE:SYK - 获取免费报告) 的评级从 “买入” 下调至 “持有”，该研究报告于周五发布。</p>
<ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
<p>其他股票研究分析师最近也对该公司发布了报告。JMP 证券在 5 月 5 日的报告中重申了 Stryker 的 “市场表现” 评级。Truist 金融在 5 月 5 日的报告中将 Stryker 的目标价格从 390.00 美元上调至 400.00 美元，并给予该股票 “持有” 评级。Evercore ISI 在 5 月 2 日的报告中将 Stryker 的目标价格从 400.00 美元下调至 390.00 美元，并为该公司设定了 “跑赢大盘” 评级。Roth Mkm 在 5 月 2 日的报告中将 Stryker 的目标价格从 405.00 美元上调至 456.00 美元，并给予该股票 “买入” 评级。最后，花旗集团在 5 月 22 日的报告中重申了 “买入” 评级，并将 Stryker 的目标价格设定为 455.00 美元（上调自 443.00 美元）。五位股票研究分析师对该股票给予了 “持有” 评级，十五位分析师给予了 “买入” 评级。根据 MarketBeat.com 的数据，Stryker 的平均评级为 “适度买入”，共识目标价格为 427.30 美元。</p>
<p><strong>获取我们对 Stryker 的最新股票分析</strong></p>
<h2>Stryker 股价上涨 0.8%</h2>
<ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
<p>在周五的午盘交易中，NYSE:SYK 上涨了 3.30 美元，达到了 393.70 美元。该公司的交易量为 2,216,556 股，而其平均交易量为 1,346,944 股。Stryker 的 52 周低点为 314.93 美元，52 周高点为 406.19 美元。该公司的 50 日移动平均线为 379.01 美元，200 日移动平均线为 375.45 美元。该公司的市值为 1502.7 亿美元，市盈率为 53.20，市盈增长比率为 2.94，贝塔值为 0.91。该公司的债务与股本比率为 0.69，速动比率为 1.00，流动比率为 1.64。</p>
<p>Stryker (NYSE:SYK - 获取免费报告) 最后一次公布季度财报是在 5 月 1 日，医疗技术公司报告该季度每股收益（EPS）为 2.84 美元，超出市场共识预期的 2.73 美元，超出幅度为 0.11 美元。Stryker 的股本回报率为 23.74%，净利润率为 12.31%。该公司在该季度的收入为 58.7 亿美元，而市场共识预期为 56.8 亿美元。在去年同期，该公司的每股收益为 2.50 美元。与去年同期相比，该季度的收入增长了 11.9%。整体来看，研究分析师预计 Stryker 在当前年度的每股收益将达到 13.47 美元。</p>
<h2>内部交易活动</h2>
<ul>
<li>Stryker 的收购狂潮：十位数增长在望</li>
</ul>
<p>在其他新闻中，董事 Ronda E. Stryker 在 5 月 6 日的交易中出售了 20 万股公司的股票，交易价格为 376.96 美元，总价值为 75,392,000.00 美元。交易完成后，该董事现在直接持有 3417326 股公司的股票，价值为 1,288,195,208.96 美元。这笔交易代表了他们持股比例的 5.53% 的减少。该交易已在向 SEC 的备案中披露，相关信息可在此链接查看。内部人士持有公司 5.90% 的股份。</p>
<h2>Stryker 的机构交易</h2>
<p>一些对冲基金最近对该公司的持仓进行了调整。Elefante Mark B 在第四季度新购入了 Stryker 的股份，价值约为 337,000 美元。Mogy Joel R Investment Counsel Inc.在第一季度将其在 Stryker 的持股增加了 3.4%。Mogy Joel R Investment Counsel Inc.现在持有 98,216 股医疗技术公司的股票，价值为 36,561,000 美元，在上个季度又购买了 3,218 股。Ferguson Wellman Capital Management Inc.在第一季度将其在 Stryker 的持股增加了 1.9%。Ferguson Wellman Capital Management Inc.现在持有 174,871 股医疗技术公司的股票，价值为 65,096,000 美元，在上个季度又购买了 3,341 股。Harbor Capital Advisors Inc.在第一季度新购入了 Stryker 的股份，价值约为 1,840,000 美元。最后，Metis Global Partners LLC 在第四季度将其在 Stryker 的持股增加了 10.2%。Metis Global Partners LLC 现在持有 16,841 股医疗技术公司的股票，价值为 6,064,000 美元，在上个季度又购买了 1,561 股。77.09% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Stryker</h2>
<p>(获取免费报告)</p>
<p>Stryker 公司作为一家医疗技术公司运营。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>如何投资 FAANG 股票</li>
<li>EA 刚刚获得了一次巨大的升级：看涨突破在前？</li>
<li>比较和交易高市盈率股票</li>
<li>3 只创历史新高的股票还有更多上涨空间</li>
<li>什么是便士股票？全面指南</li>
<li>QuantumScape 飙升 30%：是什么推动了下一代电动车股票的上涨</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Stryker 吗？</h2>
<p>在你考虑 Stryker 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
<p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

史赛克

<p>华尔街禅将史赛克（NYSE:SYK）的评级从 “买入” 下调至 “持有”。其他分析师的看法不一，JMP 证券维持 “市场表现” 评级，而 Truist Financial 将其目标价上调至 400 美元。史赛克的股票目前交易价格为 393.70 美元，市值为 1502.7 亿美元。该公司报告每股收益为 2.84 美元，超出预期，营收为 58.7 亿美元，同比增长 11.9%。内部人士 Ronda E. Stryker 最近出售了 20 万股，减少了她的持股比例 5.53%</p>

<p>Stryker (NYSE:SYK - Get Free Report) was downgraded by analysts at Wall Street Zen from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note issued on Friday.</p>
<div class="lb-trans"><p>华尔街 Zen 的分析师将 Stryker (NYSE:SYK - 获取免费报告) 的评级从 “买入” 下调至 “持有”，该研究报告于周五发布。</p>
</div><ul>
<li>If You Could Only Hold 3 Investments for Life, Consider These</li>
</ul>
<div class="lb-trans"><ul>
<li>如果你只能持有 3 项投资一辈子，请考虑这些</li>
</ul>
</div><p>Other equities research analysts also recently issued reports about the company. JMP Securities restated a &#34;market perform&#34; rating on shares of Stryker in a report on Monday, May 5th. Truist Financial increased their price objective on Stryker from $390.00 to $400.00 and gave the stock a &#34;hold&#34; rating in a report on Monday, May 5th. Evercore ISI decreased their price objective on Stryker from $400.00 to $390.00 and set an &#34;outperform&#34; rating for the company in a report on Friday, May 2nd. Roth Mkm increased their price objective on Stryker from $405.00 to $456.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, May 2nd. Finally, Citigroup reiterated a &#34;buy&#34; rating and set a $455.00 price objective (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Stryker has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $427.30.</p>
<div class="lb-trans"><p>其他股票研究分析师最近也对该公司发布了报告。JMP 证券在 5 月 5 日的报告中重申了 Stryker 的 “市场表现” 评级。Truist 金融在 5 月 5 日的报告中将 Stryker 的目标价格从 390.00 美元上调至 400.00 美元，并给予该股票 “持有” 评级。Evercore ISI 在 5 月 2 日的报告中将 Stryker 的目标价格从 400.00 美元下调至 390.00 美元，并为该公司设定了 “跑赢大盘” 评级。Roth Mkm 在 5 月 2 日的报告中将 Stryker 的目标价格从 405.00 美元上调至 456.00 美元，并给予该股票 “买入” 评级。最后，花旗集团在 5 月 22 日的报告中重申了 “买入” 评级，并将 Stryker 的目标价格设定为 455.00 美元（上调自 443.00 美元）。五位股票研究分析师对该股票给予了 “持有” 评级，十五位分析师给予了 “买入” 评级。根据 MarketBeat.com 的数据，Stryker 的平均评级为 “适度买入”，共识目标价格为 427.30 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Stryker</strong></p>
<div class="lb-trans"><p><strong>获取我们对 Stryker 的最新股票分析</strong></p>
</div><h2>Stryker Trading Up 0.8%</h2>
<div class="lb-trans"><h2>Stryker 股价上涨 0.8%</h2>
</div><ul>
<li>3 Stocks Helping to Bring AI to Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只帮助将人工智能引入医疗保健的股票</li>
</ul>
</div><p>NYSE:SYK traded up $3.30 during mid-day trading on Friday, hitting $393.70. The company had a trading volume of 2,216,556 shares, compared to its average volume of 1,346,944. Stryker has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The business's fifty day moving average is $379.01 and its two-hundred day moving average is $375.45. The firm has a market cap of $150.27 billion, a P/E ratio of 53.20, a P/E/G ratio of 2.94 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64.</p>
<div class="lb-trans"><p>在周五的午盘交易中，NYSE:SYK 上涨了 3.30 美元，达到了 393.70 美元。该公司的交易量为 2,216,556 股，而其平均交易量为 1,346,944 股。Stryker 的 52 周低点为 314.93 美元，52 周高点为 406.19 美元。该公司的 50 日移动平均线为 379.01 美元，200 日移动平均线为 375.45 美元。该公司的市值为 1502.7 亿美元，市盈率为 53.20，市盈增长比率为 2.94，贝塔值为 0.91。该公司的债务与股本比率为 0.69，速动比率为 1.00，流动比率为 1.64。</p>
</div><p>Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. During the same period in the prior year, the company earned $2.50 earnings per share. The company's revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, research analysts expect that Stryker will post 13.47 earnings per share for the current year.</p>
<div class="lb-trans"><p>Stryker (NYSE:SYK - 获取免费报告) 最后一次公布季度财报是在 5 月 1 日，医疗技术公司报告该季度每股收益（EPS）为 2.84 美元，超出市场共识预期的 2.73 美元，超出幅度为 0.11 美元。Stryker 的股本回报率为 23.74%，净利润率为 12.31%。该公司在该季度的收入为 58.7 亿美元，而市场共识预期为 56.8 亿美元。在去年同期，该公司的每股收益为 2.50 美元。与去年同期相比，该季度的收入增长了 11.9%。整体来看，研究分析师预计 Stryker 在当前年度的每股收益将达到 13.47 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><ul>
<li>Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon</li>
</ul>
<div class="lb-trans"><ul>
<li>Stryker 的收购狂潮：十位数增长在望</li>
</ul>
</div><p>In other news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 5.90% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Ronda E. Stryker 在 5 月 6 日的交易中出售了 20 万股公司的股票，交易价格为 376.96 美元，总价值为 75,392,000.00 美元。交易完成后，该董事现在直接持有 3417326 股公司的股票，价值为 1,288,195,208.96 美元。这笔交易代表了他们持股比例的 5.53% 的减少。该交易已在向 SEC 的备案中披露，相关信息可在此链接查看。内部人士持有公司 5.90% 的股份。</p>
</div><h2>Institutional Trading of Stryker</h2>
<div class="lb-trans"><h2>Stryker 的机构交易</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the business. Elefante Mark B acquired a new stake in Stryker during the 4th quarter worth approximately $337,000. Mogy Joel R Investment Counsel Inc. lifted its holdings in Stryker by 3.4% during the 1st quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock worth $36,561,000 after purchasing an additional 3,218 shares during the last quarter. Ferguson Wellman Capital Management Inc. lifted its holdings in Stryker by 1.9% during the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock worth $65,096,000 after purchasing an additional 3,341 shares during the last quarter. Harbor Capital Advisors Inc. acquired a new stake in Stryker during the 1st quarter worth approximately $1,840,000. Finally, Metis Global Partners LLC lifted its holdings in Stryker by 10.2% during the 4th quarter. Metis Global Partners LLC now owns 16,841 shares of the medical technology company's stock worth $6,064,000 after purchasing an additional 1,561 shares during the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些对冲基金最近对该公司的持仓进行了调整。Elefante Mark B 在第四季度新购入了 Stryker 的股份，价值约为 337,000 美元。Mogy Joel R Investment Counsel Inc.在第一季度将其在 Stryker 的持股增加了 3.4%。Mogy Joel R Investment Counsel Inc.现在持有 98,216 股医疗技术公司的股票，价值为 36,561,000 美元，在上个季度又购买了 3,218 股。Ferguson Wellman Capital Management Inc.在第一季度将其在 Stryker 的持股增加了 1.9%。Ferguson Wellman Capital Management Inc.现在持有 174,871 股医疗技术公司的股票，价值为 65,096,000 美元，在上个季度又购买了 3,341 股。Harbor Capital Advisors Inc.在第一季度新购入了 Stryker 的股份，价值约为 1,840,000 美元。最后，Metis Global Partners LLC 在第四季度将其在 Stryker 的持股增加了 10.2%。Metis Global Partners LLC 现在持有 16,841 股医疗技术公司的股票，价值为 6,064,000 美元，在上个季度又购买了 1,561 股。77.09% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Stryker</h2>
<div class="lb-trans"><h2>关于 Stryker</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.</p>
<div class="lb-trans"><p>Stryker 公司作为一家医疗技术公司运营。该公司通过两个部门运营，分别是 MedSurg 和神经技术，以及骨科和脊柱。骨科和脊柱部门提供用于全关节置换的植入物，如髋关节、膝关节和肩关节，以及创伤和四肢手术。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Stryker</li>
<li>How to Invest in the FAANG Stocks</li>
<li>EA Just Caught a Monster Upgrade: Bullish Breakout Ahead?</li>
<li>Comparing and Trading High PE Ratio Stocks</li>
<li>3 Stocks Hitting All-Time Highs With More Room to Run</li>
<li>What is a penny stock? A comprehensive guide</li>
<li>QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Stryker</li>
<li>如何投资 FAANG 股票</li>
<li>EA 刚刚获得了一次巨大的升级：看涨突破在前？</li>
<li>比较和交易高市盈率股票</li>
<li>3 只创历史新高的股票还有更多上涨空间</li>
<li>什么是便士股票？全面指南</li>
<li>QuantumScape 飙升 30%：是什么推动了下一代电动车股票的上涨</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNZSw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=SYK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Stryker Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Stryker 吗？</h2>
</div><p>Before you consider Stryker, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Stryker 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而史赛克并不在名单上。</p>
</div><p>While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然史赛克目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

华尔街禅将史赛克公司（NYSE:SYK）的评级下调至持有